Fine

Quick links to important sections

Fine

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fine

Quick Facts

Property Description
Active ingredient Finasteride (INN)
Form Oral Tablet
Pharmacological class 5-alpha reductase inhibitor
Origin Synthetic (chemically produced)
Type Single-ingredient product

Understanding Finasteride's Core Identity

Finasteride is a prescribed medicine that is classified pharmacologically as a 5-alpha reductase inhibitor. This classification is clinically recognized for its specific mechanism of modulating hormonal processes involved in cell growth, a concept supported by pharmacological studies published by the [NIH (National Institutes of Health)](

Finasteride is the official International Nonproprietary Name (INN) for this substance. It is a synthetic compound, manufactured through chemical synthesis rather than being naturally derived. It is consistently formulated as a single-ingredient product, meaning the Finasteride molecule is solely responsible for the drug’s primary effect.

Finasteride's Form and General Purpose

The medicine is typically supplied as an oral tablet, which is the intended route of administration. This dosage form is designed to provide a uniform, systemic effect throughout the body, ensuring the medicine reaches internal target tissues effectively.

The central purpose of Finasteride is to reduce the levels of the potent male hormone dihydrotestosterone (DHT) by blocking the specific enzyme responsible for its production. This action is leveraged to provide relief in general scenarios where excessive DHT activity leads to tissue changes. The [FDA (U.S. Food and Drug Administration)]( confirms that this mechanism supports the management of issues related to prostate enlargement and the slowing of hormonally-related hair thinning.

Therapeutic Uses of Fine

What Fine Treats: Main Uses and Benefits

The primary therapeutic role of Fine, a dual-action medication combining an analgesic and a selective calcium channel blocker, is generally applied across domains where additional symptomatic support is needed. This combination is commonly used in clinical settings marked by increased discomfort or tension, relevant when supportive symptom management is appropriate, as supported by **[NIH StatPearls on Migraine Prophylaxis](

Fine is commonly used for the prophylaxis (prevention) of migraine headaches, particularly in individuals experiencing frequent, severe, or disabling episodes. The medication is considered relevant in conditions characterized by periods of heightened symptoms, including chronic headaches, vascular headaches, and vertigo associated with neuro-vascular instability. This approach helps patients cope more steadily with symptom fluctuations, providing support that helps ease the overall symptom burden.

In clinical scenarios, Fine is applied during phases when symptoms become more noticeable, offering short-term supportive relief in situations involving symptoms related to physical discomfort, such as acute pain and fever. This assists with maintaining functional stability and provides supportive relief when symptoms become temporarily overwhelming.


Quick Fact: Relief for Recurrent Symptoms

Fine helps with managing symptom clusters that may become intense or disruptive, contributing to improved comfort during periods of heightened symptoms.

Regulatory References

  1. NIH StatPearls on Migraine Prophylaxis

Mechanism of Action

Finasteride acts as a competitive inhibitor of the enzyme 5-alpha reductase (5AR), preferentially engaging the Type II and Type III isoenzymes. This molecular action physically prevents the enzyme from catalyzing the conversion of the hormone testosterone into its active metabolite, dihydrotestosterone (DHT). The resulting molecular blockade leads to a significant reduction of DHT levels systemically and locally within responsive tissues. The reduced concentration of DHT lessens the hormonal stimulus for cellular proliferation. The physiological consequence of this is the suppression of excessive cell activity within responsive tissues. The effect is constrained by Finasteride's weaker inhibition of the 5AR Type I isoenzyme, which allows for some residual DHT synthesis. Additionally, the physiological adjustment is a slow process dependent on cellular turnover and tissue remodeling, reflecting the delayed kinetics required for tissue restructuring.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fine found in:

A-Z Index: